Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Home
Editors' (re)View
Welcome to Editors' (re)View, our editors’ weekly takes on things going on in the pharma world that deserve some extra consideration.
Articles
Editors' (re)View: Boehringer’s AI push; Busy week for Phenomic
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of November 27
Editors' (re)View: Meals minus the stuffing; Antibiotics in your turkey?
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of November 20
Editors' (re)View: A historic moment in biotech
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of November 13.
Editors' (re)View:Contraception gel less effective than claims; Can tirzepatide usurp Humira?
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of November 6
Editors' (re)View: Hope for BCG alternatives; AdComm casts positive light on SCD therapy
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 30
News
Novo obesity drug reduces heart failure-related symptoms
Editors (re)View: Innovative takeaways from CPHI
Bright ideas shine on the tradeshow floor
Editors' (re)View: Innovating to meet customer needs; ADC moves
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 16.
Editors' (re)View: EU rejects Amylyx ALS drug; Alvotech's problematic Reykjavik facility
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 10
Editors' (re)View: Lilly goes radioactive; Pharma fights back against the FTC
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 2
Editors' (re)View: COVID BARDA bucks; BrainStorm ALS hopeful fails to impress
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 25
Editors' (re)View: Nasal epinephrine hits roadblocks; Mesoblast comes closer to winning
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 18
Editors' (re)View: Phenylephrine doesn't work; J&J changes the script
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 11.
Editors' (re)View: Nestlé gives up on peanut allergy drug; Next-level ADCs
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 4
Editors' (re)View: Outlook stays positive; FTC clears Amgen-Horizon deal
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of August 28
Editors' (re)View: Affordable MS treatment option; A chance to date Martin Shkreli
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of August 21
Load More Content